New protocol accurately diagnoses pediatric anesthetic allergy
The study involved 88 pediatric patients, with 12.5% showing positive intradermal test results and 1.1% positive subcutaneous provocation.
FDA announces measures to out petroleum-based food dyes
One step will be a partnership with the National Institutes of Health to research how food additives impact children's health.
PNP perspective: Nasal epinephrine spray approved for children as young as 4 years
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest print issue of Contemporary Pediatrics
Confirming celiac disease is getting easier
"We are getting away from biopsies to diagnose CD, which makes diagnosis even easier, said Jon Matthew Farber, MD.
Poll shows many parents unsure when to talk to kids about puberty
Most want to start the conversation, but confidence and timing vary.
Sensory play for children with autism, with Joshua Feder, MD
Joshua Feder, MD, emphasizes that sensory play is most effective when rooted in relational strategies that support autistic children in daily environments.
New blood test predicts preterm birth risk early in pregnancy
A new study found that cell-free DNA from routine prenatal testing can accurately identify preterm birth risk without added cost or procedures.
Do probiotics reduce allergy symptoms? It’s complicated!
In 3 studies evaluating the effects of probiotics on eczema, probiotics groups reported a greater reduction in symptoms than placebo groups, but only when the allergy was IgE mediated.
Weekly review: FDA approves dupilumab, ACIP meets, and more
From the FDA approvals of dupilumab and maralixibat tablets to a new puzzler case study, get caught up with our weekly review article.
FDA issues CRL for aflibercept 8 mg extended dosing for all indications
The CRL issued by the FDA to Regeneron for extended EYLEA HD dosing to 24 weeks cited no safety or efficacy concerns.
The crucial role pediatricians play in early autism diagnosis and why it matters
Find out how pediatricians play a crucial role in early autism diagnosis and how to advise families post-diagnosis.
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up
The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU.
Viral studies reduce antibiotic use in hospitalized febrile infants
"Testing for viruses should be the standard of care to help guide therapy," stated Jon Matthew Farber, MD.
ACIP votes in favor of recently FDA approved vaccines for meningococcal disease, chikungunya
Recommendations from the ACIP are forwarded to the director of the CDC, and if adopted, become official CDC policy.
Full case: 2-month-old with scalp swelling
FDA expands diazepam nasal spray for seizure clusters to ages 2–5
Diazepam nasal spray (Valtoco) is approved for short-term treatment of seizure clusters, now in patients aged 2 years and older.
Stephanie Chao, MD details relationships in mass shootings involving children
Recent research detailed that a child was most likely to be killed in a mass shooting by a parent or family member vs a stranger or peer. Study investigator Stephanie Chao, MD, breaks down these data.
Preterm skin-to-skin contact does not improve neurodevelopment at 2–3 years
In the immediate skin-to-skin contact group, improved breastfeeding practices up to 12 months were observed.
Six months of breastfeeding tied to lower risk of developmental delays
Breastfeeding for 6 months was linked to fewer developmental delays and neurodevelopmental conditions, supporting current recommendations.
Child dehydration: Early signs to watch for
Their smaller size, higher metabolic rate, and greater body water percentage mean they lose fluids more quickly.
Identifying motor milestone delay can lead to earlier autism diagnosis
Overall, findings revealed that a higher proportion of children with autism had a history of motor milestone delays.
FDA approves maralixibat tablet formulation for ALGS and PFIC
In the United States, maralixibat (Livmarli; Mirum Pharmaceuticals) is approved to treat both ALGS and PFIC, now in liquid and tablet formulations.
Preterm birth associated with long-term cognitive issues in children
Infants born moderately preterm had lower composite cognitive scores compared to those born at full-term s (β = −0.39; 95% CI, −0.55 to −0.22; P < .001).
Weekly review: Strong plaque psoriasis data, our April issue, and more
From strong data for JNJ-2113 to a deep dive into climate change and pediatric health care, get caught up with our weekly review article.
IL-6 may aid in early sepsis detection in children, newborns
A recent study found IL-6 may help with earlier sepsis detection in pregnant women, children, and newborns, outperforming traditional diagnostic tests.
Quiz: AAP critical congenital heart disease screening recommendations
Do you know the details from the American Academy of Pediatrics' 2024 CCHD updated screening recommendations?
Talking to parents about seed oils
While these concerns are often rooted in misinformation, they offer an opportunity to guide families back to the evidence.
JNJ-2113 for plaque psoriasis demonstrates clear skin in 75% of adolescents
“Data from the Phase 3 ICONIC LEAD subgroup analysis demonstrate impressive efficacy rates, showing the promise of this novel therapeutic option," said Lawrence Eichenfield, MD.
Most US teen girls live in states with abortion limits
Two-thirds of US teen girls live in states with abortion bans, gestational limits, or parental involvement laws, limiting access to care.
Climate change: Challenges faced by the pediatric population
The World Bank Group reports that as this global health emergency escalates, devastating impacts on health and well-being will also accelerate.
